Episode Description

Oguzhan is the co-founder and CEO of BilliontoOne, a precision diagnostics company that makes molecular diagnostics accurate, efficient, and accessible for all. Born and raised in Turkey, Oguzhan studied Molecular Biology at Princeton University and received his PhD in Systems Biology from Stanford University. If that wasn’t enough star power in his resume, he also took his company to YC, only to raise $32M afterwards from the likes of Hummingbird Ventures, Neotribe Ventures and 500 Startups.

In this episode, we explore the groundbreaking work of BillionToOne, a company revolutionizing early detection in healthcare through innovative molecular diagnostics. The discussion delves into their mission to make critical healthcare insights more accessible and accurate, the technology powering their advancements, and the impact they are making in the field.

From the challenges of scaling scientific breakthroughs to the broader implications for global healthcare, this conversation provides a unique look at the intersection of science, technology, and entrepreneurship. Whether you’re passionate about healthcare innovation or simply inspired by companies making a difference, this episode is packed with insights and inspiration.

What’s in this episode?

1) BilliontoOne’s rapid speed in going to market in biotech space

2) Receiving funding from specialized VCs vs generalists in biotech space

3) Use of "back-home" or "non-US" sources and methods in building product

4)BilliontoOne’s future vision for product development and geographic coverage

5)Competing with large incumbents and public companies